Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 5.53%, which ...

Avior Wealth Management LLC boosted its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 10.4% during the 4th quarter, according to the company in its most recent filing with the ...

Elevance Health Inc (ELV) stock saw a decline, ending the day at $400.96 which represents a decrease of $-0.40 or -0.10% from the prior close of $401.36. The stock opened at $397.16 and touched a low ...

Elevance Health (NYSE:ELV – Free Report) had its price target upped by Barclays from $501.00 to $512.00 in a report published on Friday,Benzinga reports. The firm currently has an overweight rating on ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ServiceNow, Inc. (NOW), Alibaba Group ...

Fifth Third Bancorp cut its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 26.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The ...

The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, ...

Paul MacDonald, CIO and portfolio manager at Harvest Portfolios Group Focus, shares his past picks; Stryker, Abbott ...

The Public Health Agency of Canada is part of the federal health portfolio. Our activities focus on protecting against threats to public health, preventing and reducing diseases and injury, and ...